Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Army
Cerilliant
Moodys
Deloitte
Farmers Insurance
QuintilesIMS
Covington
Johnson and Johnson
Julphar

Generated: January 22, 2018

DrugPatentWatch Database Preview

Carteolol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carteolol hydrochloride and what is the scope of carteolol hydrochloride patent protection?

Carteolol hydrochloride
is the generic ingredient in three branded drugs marketed by Apotex Inc, Bausch And Lomb, Sandoz Inc, Novartis, and Abbvie, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for carteolol hydrochloride. Two suppliers are listed for this compound.
Pharmacology for carteolol hydrochloride
Medical Subject Heading (MeSH) Categories for carteolol hydrochloride

US Patents and Regulatory Information for carteolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-001 Dec 28, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CARTEOLOL HYDROCHLORIDE carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075476-001 Jan 3, 2000 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis OCUPRESS carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019972-001 May 23, 1990 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc CARTEOLOL HYDROCHLORIDE carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 076097-001 Feb 6, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb CARTEOLOL HYDROCHLORIDE carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075546-001 Jan 20, 2000 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-002 Dec 28, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-003 Dec 28, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for carteolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis OCUPRESS carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019972-001 May 23, 1990 ➤ Subscribe ➤ Subscribe
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-003 Dec 28, 1988 ➤ Subscribe ➤ Subscribe
Novartis OCUPRESS carteolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019972-001 May 23, 1990 ➤ Subscribe ➤ Subscribe
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-001 Dec 28, 1988 ➤ Subscribe ➤ Subscribe
Abbvie CARTROL carteolol hydrochloride TABLET;ORAL 019204-002 Dec 28, 1988 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Army
Mallinckrodt
AstraZeneca
Healthtrust
Boehringer Ingelheim
Novartis
Colorcon
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot